Aurangabad company that is Conducting Transformational Clinical Trials: Aiding in the treatment of Covid, dengue, eyesight patients

Krutikesh Age

A company that played an instrumental role in conducting clinical trials and in the treatment of covid, dengue and other ailments is DPHS. Pvt. Ltd. Founded in 2020, the company has conducted several new clinical trials during the lockdowns.

In its first trial in 2020, a small team of treated patients for Covid-19 and later they were successful in treating patients for Covid under the guidance of Krutikesh Age and Ankesh Pawar. Continuing its efforts, the third project that the company took was an ophthalmology biological project. In this project, patients were treated by the team who were able to regain their lost eyesight, thereby changing their lives for better.

DPHS also conducted Study of Sunitinib in the indication Advanced Renal Cell Carcinoma and GIST in which subjects were collectively enrolled. In a span of two months which was the highest recruitment considering all the factors and parameters at time of screening and enrolment which includes the rareness of the disease. Sunitinib was costlier treatment at times which was given to the patient at free of cost. The trail subjects were taken utmost care and patient safety was the central focus. Moving further DPHS had conducted other clinical trials in indication such as Triple Negative Breast Cancer (TNBC) and Metastatic Breast cancer (MBC) in which the team screened and subjects respectively in short period of time. Moreover, the team of DPHS is skilled at timely completion of data with strict following the protocol. They have also done Studies in other Oncology indication such as Advanced ovarian cancer in which total subjects were enrolled, CA Prostate, etc.

Speaking on the successful treatments so far, Krutikesh Age, Co-founder said, "We started with our first covid project in April in association with SUN Pharma with a small team of people and ever since we have only grown and expanded our approach towards treating patients suffering from covid, eyesight issues, dengue, cardiac problems to name a few. Today we are a team of and are focused towards conducting intense clinical studies for our clients, thereby helping the society at large."

The journey has been ongoing, and the team has been working on clinical studies for Renal cell carcinoma, wherein the team screened and treated. Additionally, Cardiac study for subjects roughly; dengue study treating approximately patients; oncology study under the guidance of Abhijit Patil and much more.

Speaking about the overall working of DPHS, it is a clinical research, development, diagnostics, and data management solutions company aiding businesses with clinical trial services across all phases- Drug Development Solutions, Early Phase Solutions, Clinical Development and Clinical Trial Liaisons, has brought about a revolution in the space of healthcare over the short span of past years with its exceptional innovative research and treatment practices.

Moving on to the Other Clinical Trials in other Therapeutic areas, DPHS has also conducted and has expertise in Ophthalmological trials. They have Principal Investigators who are experienced in doing Global Clinical Trials and team has conducted Trial of Wet Age-related Macular Degeneration (Wet ArMD) in which total Subjects were screened and in which Subjects were enrolled on one site who completed the Study period to End of the Study, collectively subjects were screened in the study from our all sites combined. The team at DPHS have conducted cataract clinical trials in which subjects were screened and enrolled and were the highest recruiter. In field of ophthalmology, they have also conducted Global Studies of WET ArMD, DME. With the help of top-notch instruments and globally accepted such as OCT machine, Fluorescence angiography machine, Fluorescence Photography Machines, Topography Machines, Slit Lamp Examination Equipment, etc.

At DPHS, the team works side-by-side with the clients, to move medicine discovery forward, and to help them develop life-saving and life-improving medicines. The brand has been helping to bring to market everything from niche treatments and therapies to blockbuster drugs. Providing comprehensive Phase I-IV pharmaceutical drug development in multiple cities, DPHS is dedicated to being innovative, and to delivering unmatched scientific expertise that improves the drug development process.

To maximize safety and efficiency and make data-driven decisions for every research, the DPHS team collaborates closely with its sponsors to build flexible, strategic methods that make use of cutting-edge technology, clinical informatics, and a worldwide reach. Additionally, thanks to the effective use of technology, the integration of clinical and bioanalytical services, and exclusive access to patients, the brand boasts a on-time study start and completion record.

DPHS has a list of endeavors in pipeline that depict a diverse range of clinical trials in cardiology, oncology, diabetes, and vaccine development. Some of these studies are about to begin, reflecting our proactive response to healthcare needs. While a few may require additional preparation, rest assured that the patient's safety and well-being are the top priorities as DPHS advances in medical knowledge and patient care.

The extensive operational and research knowledge is to credit for the pharma brand's exponential growth over the previous two years. The pharmaceutical brand, which now operates in five cities across the nation, intends to grow in Rajasthan and Karnataka and become a unicorn firm in the coming years.